product Guide-Soothing Active

Our anti-irritation line has a single grade. That is a decision, not a gap.

YLBMS was developed for one narrow job: calming the sensation of itch and the look of redness. Rather than build a family of near-duplicates, we put that effort into characterising one molecule thoroughly — so you get a well-documented dossier instead of a choice between three similar options.

That means this guide does not compare grades. It answers the two questions that actually matter: how much to use, and what to pair it with.

The product

What the testing showed

The molecule’s design was benchmarked against established soothing reference molecules, which is why it works at low concentrations. Full test reports are available to your R&D team.

How to choose the use level

Use levels above are development starting points, not formulation instructions. Always confirm with stability and tolerance testing.

Choosing the right system to carry it

The active is only half the answer. The base determines whether consumers actually feel the difference.

Explore the full range of bases in the Emulsifiers and Synthetic Esters guides.

Formulation notes

• pH window is broad (3–8), which means YLBMS can sit in acidic brightening systems as well as near-neutral creams.
• Add in the cool-down phase, as with most heat-sensitive actives, and confirm the exact window against the TDS and your own stability testing.
• Pair don’t pile. When a formula contains several potentially reactive actives — acids, high-dose vitamin C or resorcinols — YLBMS is usually more effective than adding further soothing agents on top.
• Combine with XON-free positioning carefully. Verify each supporting ingredient against your retailer’s restricted-substance list.

Claims and compliance notes — important

This is the area where finished-product copy most often goes wrong.

Our recommendation: keep mechanism language in your technical dossier and use sensory language on pack. “Calms the feel of itch”, “reduces the look of redness” and “developed for sensitive skin” travel much further across markets than mechanism claims, and they rarely need rework at registration.

Additional points:

• Where you quote a percentage, always attach the study design and conditions to it.
• “Hypoallergenic” and “dermatologically tested” each require their own specific testing protocol — do not assume they follow from soothing data.
• Documentation: batch COA, TDS, SDS/MSDS, full efficacy test reports, documentation where applicable, retained samples and batch traceability.
• Data quoted here come from internal and commissioned testing. The official batch COA and test report govern.

Two audiences, two notes

If you are a formulator: request a sample plus the full test report, and run a 0.2% / 0.5% / 1.0% ladder in your own base. The response curve is steep between 0.2% and 1.0%, and most products do not need the top of the range.

If you are a distributor: this is the easiest line to open a new customer with. Sensitive skin and after-sun are growing categories, the addition level is low, and — because we supply one well-characterised grade rather than a confusing family — the sales conversation stays simple. Every soothing conversation starts and ends with the same code.

Frequently asked questions

Why is there only one product in this line? Because the brief was narrow. Rather than offer several near-duplicate soothing agents, we characterised one thoroughly — with human and model testing backing it — so you get stronger documentation instead of a wider menu.

What is the difference between using it at 0.2% and at 1%? Low levels suit daily maintenance and sensitive-skin care; higher levels suit acute situations like after-sun and after-bite formats. Run a ladder in your own base to find the point where return stops justifying cost.

Can I use it in an acidic formula? Yes — the pH window is 3–8. For acidic brightening or blemish-care emulsions, pair it with YLTRISTAB, which holds pH 3–6.

Is it suitable for baby care? It is commonly selected for baby-care applications at 0.2–0.5%. Confirm with your own tolerance assessment.

What documents come with a sample? TDS, SDS/MSDS and COA ship with the sample; full efficacy test reports are available to your R&D team on request, normally within 24 hours.

What are lead times and MOQ? Standard lead time is 7–30 days with flexible MOQ and sample sizes available for evaluation.

Continue through the series

Brightening Actives → · Emulsifiers → · Surfactants → · Synthetic Esters → · Preservative Alternatives →

Ready to shortlist? Tell us your application, target use level and claims concept, and our team will return a recommended formulation route with samples and test reports — usually within one working day. Request samples and documentation · fiona@ingrelink.com · +86 186 8017 1796

Guangzhou IngreLink New Material Co., Ltd. — Sincerity · Agility · Win-Win. Data referenced are from internal and commissioned testing; the official batch COA and test report govern. Cosmetic ingredients only — not for drug or medical use. Finished-product claims, registration and labelling are the responsibility of the brand.